Invesaro

Stocks CRWV Financial statements

Financial statements

CoreWeave, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 3 fiscal years, taken from the XBRL data CoreWeave, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2023FY2025FY2025
Revenue2291,9155,131
Cost of revenue694931,453
Gross profit1601,4223,678
Research and development2156352
Selling and marketing1318144
General and administrative30119651
Operating income-14324-46
Interest expense273491,148
Other non-operating income184933
Pre-tax income-558-744-1,215
Income tax36119-48
Net income-594-863-1,167
EBITDA891,1872,408
EPS, basic-3.09-4.30-2.75
EPS, diluted-3.09-4.30-2.81
Shares, basic (weighted)192218435
Shares, diluted (weighted)192218436
Dividend per share0.000.00

Balance sheet

FY2023FY2025FY2025
Cash and equivalents2171,3613,127
Short-term investments034
Receivables4173,169
Other current assets34140
Total current assets1,9167,488
Property, plant and equipment11,91530,557
Lease right-of-use assets2,5908,231
Goodwill0201,101
Intangible assets5235
Long-term investments290
Other non-current assets7211,506
Total assets17,83349,302
Accounts payable8681,623
Accrued liabilities3565,773
Deferred revenue7691,709
Short-term debt2,4686,708
Total current liabilities4,96316,440
Long-term debt5,45814,665
Lease liabilities2,3897,768
Other non-current liabilities37287
Total liabilities16,52545,967
Total debt7,92621,373
Paid-in capital1,0966,012
Retained earnings-1,476-2,643
Treasury stock-34-34
Other comprehensive income00
Shareholders' equity-597-4143,335
Total equity-597-4143,335
Total liabilities and equity17,83349,302

Cash flow statement

FY2023FY2025FY2025
Net income-594-863-1,167
Depreciation and amortization1038632,454
Stock-based compensation1531630
Deferred income tax36113-53
Change in receivables-162-280-2,749
Change in payables27511253
Cash from operations1,8332,7493,058
Capital expenditures-2,943-8,702-10,309
Acquisitions00-108
Purchases of investments-172-34-47
Sales and maturities of investments618843
Cash from investing-3,148-8,658-10,271
Debt issued1,4047,01811,829
Debt repaid-2-589-3,399
Stock issued1500
Cash from financing1,7887,4649,308
Net change in cash4731,5552,095
Free cash flow-1,110-5,953-7,251
Interest paid0184869
Income taxes paid014-1

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $87.59 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin67.4%Gross profit / revenue.
Operating margin-3.0%Operating income / revenue.
EBITDA margin49.5%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-25.3%Pre-tax income / revenue.
Net margin-25.4%Net income / revenue.
FCF margin-179.9%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin91.1%Cash from operations / revenue.
Return on equity (ROE)-38.4%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-2.5%Net income / average total assets.
R&D / revenue5.6%Research and development expense / revenue.
Stock-based pay / revenue8.2%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue271.0%Capital expenditures / revenue.
D&A / revenue52.6%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y167.9%Revenue vs the same period a year earlier. Only from a positive base.
Gross profit growth, 1y158.7%Gross profit vs the same period a year earlier. Only from a positive base.
Operating income growth, 1y-114.2%Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y102.9%EBITDA vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y11.2%Operating cash flow vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y176.5%Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y100.0%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.46xCurrent assets / current liabilities.
Quick ratio0.39x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.26x(Cash + short-term investments) / current liabilities.
Liabilities / assets93.5%Total liabilities / total assets.
Interest coverage-0.14xOperating income / interest expense.
Working capital-$11.40BCurrent assets - current liabilities.
Goodwill and intangibles / assets1.7%(Goodwill + intangible assets) / total assets.
Tangible book value$3.68BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.10xRevenue / average total assets.
Fixed asset turnover0.16xRevenue / average property, plant and equipment.
Receivables turnover2.99xRevenue / average receivables.
Days sales outstanding122 days365 x average receivables / revenue.
Days payables536 days365 x average accounts payable / cost of revenue.
Capex / operating cash flow297.6%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted-$3.50Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$13.78Revenue / diluted weighted shares.
FCF per share-$24.78Free cash flow / diluted weighted shares.
Operating cash flow per share$12.54Cash from operations / diluted weighted shares.
Book value per share$9.12Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$6.68Tangible book value / shares outstanding.
Cash per share$10.05(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$48.31BShare price x shares outstanding.
Enterprise value$42.77BMarket cap + total debt - cash - short-term investments.
P/S6.36xMarket cap / revenue.
P/B9.62xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book13.1xMarket cap / tangible book value, when positive.
P/OCF6.99xMarket cap / cash from operations, when positive.
EV/Sales5.64xEnterprise value / revenue.
EV/EBITDA11.4xEnterprise value / EBITDA, when both are positive.
FCF yield-28.3%Free cash flow / market cap.
Earnings yield-4.0%Net income / market cap (the inverse of P/E).
What was CoreWeave, Inc.'s revenue in fiscal 2025?

CoreWeave, Inc. reported revenue of $5.13B for fiscal 2025, 167.9% higher than the year before.

Was CoreWeave, Inc. profitable in fiscal 2025?

No. It reported a net loss of $1.17B.

How much free cash flow did CoreWeave, Inc. generate in fiscal 2025?

Cash from operations of $3.06B minus capital expenditures of $10.31B left free cash flow of -$7.25B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to CoreWeave, Inc.